Immuno-Pet Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-In-Human Trial
Journal of Nuclear Medicine - China
doi 10.2967/jnumed.116.172221
Full Text
Open PDFAbstract
Available in full text
Date
May 26, 2016
Authors
Publisher
Society of Nuclear Medicine